Holen Sie sich die Stockscreener-App
13.11
2.38%
-0.32
Vorhandelsmarkt:
13.13
0.02
+0.15%
Schlusskurs vom Vortag:
$13.43
Offen:
$13.525
24-Stunden-Volumen:
655.47K
Relative Volume:
0.63
Marktkapitalisierung:
$390.00M
Einnahmen:
$30.43M
Nettoeinkommen (Verlust:
$-18.15M
KGV:
-19.00
EPS:
-0.69
Netto-Cashflow:
$-9.08M
1W Leistung:
-6.89%
1M Leistung:
-20.69%
6M Leistung:
-1.35%
1J Leistung:
-21.40%
1-Tages-Spanne:
$13.02
$13.53
1-Wochen-Bereich:
$13.02
$14.19
52-Wochen-Spanne:
$9.76
$30.10
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Firmenname
Clearpoint Neuro Inc
Sektor
Branche
Telefon
(949) 900-6833
Adresse
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Vergleichen Sie CLPT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLPT
Clearpoint Neuro Inc
|
13.11 | 399.52M | 30.43M | -18.15M | -9.08M | -0.69 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2023-10-24 | Eingeleitet | Stifel | Buy |
| 2023-02-16 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-04-05 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-03-18 | Eingeleitet | Lake Street | Buy |
| 2020-07-17 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Clearpoint Neuro Inc Aktie (CLPT) Neueste Nachrichten
Trend Review: Will ClearPoint Neuro Inc. stock outperform Nasdaq index2025 Market WrapUp & Weekly Setup with ROI Potential - BỘ NỘI VỤ
Geode Capital Management LLC Buys 323,429 Shares of ClearPoint Neuro, Inc. $CLPT - MarketBeat
Here’s What Boosted ClearPoint Neuro (CLPT) in Q3 - Insider Monkey
Can ClearPoint Neuro Inc. stock withstand economic slowdownMarket Sentiment Review & Free Safe Entry Trade Signal Reports - Newser
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $30 - 富途牛牛
Is ClearPoint Neuro Inc. stock positioned well for digital economyPortfolio Risk Summary & Daily Entry Point Alerts - Newser
ClearPoint Neuro (CLPT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will ClearPoint Neuro Inc. stock maintain dividend yieldJuly 2025 Macro Moves & Free Daily Entry Point Trade Alerts - Newser
CLPT SEC FilingsClearpoint Neuro Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT) and Bristol-Myers Squibb (BMY) - The Globe and Mail
[Form 4] ClearPoint Neuro, Inc. Insider Trading Activity - Stock Titan
What analysts say about ClearPoint Neuro Inc stockGlobal Trade Effects & Superior Growth Investment - earlytimes.in
Analysts Offer Insights on Healthcare Companies: Delcath Systems (DCTH) and ClearPoint Neuro (CLPT) - The Globe and Mail
What drives ClearPoint Neuro Inc stock priceMarket Sentiment Report & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
ClearPoint Neuro Completes Acquisition of IRRAS Holdings - MSN
ClearPoint Neuro completes acquisition of IRRAS Holdings - Investing.com India
ClearPoint Neuro completes acquisition of IRRAS Holdings By Investing.com - Investing.com Australia
How (CLPT) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
[8-K] ClearPoint Neuro, Inc. Reports Material Event | CLPT SEC FilingForm 8-K - Stock Titan
ClearPoint Neuro Completes Acquisition of IRRAS - ACCESS Newswire
ClearPoint (Nasdaq: CLPT) closes IRRAS deal, adding IRRAflow and 50+ customers - Stock Titan
Is ClearPoint Neuro Inc. stock a top pick in earnings seasonShare Buyback & Real-Time Volume Spike Alerts - newser.com
Will ClearPoint Neuro Inc. stock attract more institutional investorsJuly 2025 Trends & Safe Capital Growth Tips - newser.com
ClearPoint Neuro, Inc. completed the acquisition of Irras Holdings Inc. - MarketScreener
How ClearPoint Neuro Inc. stock performs during Fed tightening cycles2025 Top Decliners & Short-Term Swing Trade Alerts - newser.com
Using economic indicators to assess ClearPoint Neuro Inc. potential2025 Market Trends & Safe Swing Trade Setups - newser.com
Will ClearPoint Neuro Inc. stock deliver long term returns - newser.com
ClearPoint Neuro Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Campbell & CO Investment Adviser LLC Purchases New Stake in ClearPoint Neuro, Inc. $CLPT - MarketBeat
CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.0 - MSN
What margin trends mean for ClearPoint Neuro Inc. stockPortfolio Gains Report & Safe Entry Zone Identification - newser.com
What risks investors should watch in ClearPoint Neuro Inc. stockPortfolio Update Summary & AI Forecast for Swing Trade Picks - newser.com
Why ClearPoint Neuro Inc. stock could be next big winnerInsider Selling & Weekly Chart Analysis and Guides - newser.com
How resilient is ClearPoint Neuro Inc. stock in market downturnsJuly 2025 News Drivers & Real-Time Buy Signal Alerts - newser.com
ClearPoint Neuro (NASDAQ:CLPT) Cut to Sell at Wall Street Zen - MarketBeat
ClearPoint Neuro’s Strategic Growth Highlighted in Earnings Call - MSN
Will ClearPoint Neuro Inc. stock outperform growth indexes2025 Macro Impact & Community Consensus Stock Picks - Fundação Cultural do Pará
Earnings call transcript: ClearPoint Neuro Q3 2025 misses revenue forecast By Investing.com - Investing.com South Africa
Earnings call transcript: ClearPoint Neuro Q3 2025 misses revenue forecast - Investing.com India
Despite currently being unprofitable, ClearPoint Neuro (NASDAQ:CLPT) has delivered a 66% return to shareholders over 5 years - Yahoo Finance
Can ClearPoint Neuro Inc. stock hit record highs again2025 Fundamental Recap & Daily Stock Momentum Reports - newser.com
Finanzdaten der Clearpoint Neuro Inc-Aktie (CLPT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):